Timothy A. Graubert

25.3k total citations · 1 hit paper
112 papers, 5.9k citations indexed

About

Timothy A. Graubert is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Timothy A. Graubert has authored 112 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Hematology, 59 papers in Molecular Biology and 18 papers in Immunology. Recurrent topics in Timothy A. Graubert's work include Acute Myeloid Leukemia Research (60 papers), RNA Research and Splicing (14 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Timothy A. Graubert is often cited by papers focused on Acute Myeloid Leukemia Research (60 papers), RNA Research and Splicing (14 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Timothy A. Graubert collaborates with scholars based in United States, United Kingdom and Switzerland. Timothy A. Graubert's co-authors include Timothy J. Ley, Matthew J. Walter, John F. DiPersio, Margaret A. Goodell, Sujan Shresta, Dori A. Thomas, John H. Russell, Elaine R. Mardis, Jeffrey M. Rosen and Bryan E. Welm and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Timothy A. Graubert

106 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity

2019 613 citations Richard M. Stone, Timothy A. Graubert et al. profile →

Peers

Countries citing papers authored by Timothy A. Graubert

Since Specialization

Citations

This map shows the geographic impact of Timothy A. Graubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy A. Graubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy A. Graubert more than expected).

Fields of papers citing papers by Timothy A. Graubert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy A. Graubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy A. Graubert. The network helps show where Timothy A. Graubert may publish in the future.

Co-authorship network of co-authors of Timothy A. Graubert

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy A. Graubert. A scholar is included among the top collaborators of Timothy A. Graubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy A. Graubert. Timothy A. Graubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	3067 – ATR/CHK1/WEE1 DEPENDENCY IN SRSF2-MUTATED MDS/AML 2024 ·Experimental Hematology ·Samuli Eldfors, (unknown), Vineet K. Sharma, (unknown), Claudia Cabrera, Amy M. Bertino, (unknown), (unknown), Kimmo Porkka, Timothy A. Graubert	0
2	Safety and Activity of the TIM3 Inhibitor Sabatolimab in Patients with Lower-Risk Myelodysplastic Syndromes 2024 ·Blood ·Andrew M. Brunner, Yiwen Liu, Rupa Narayan, Michelle Lee, Philip C. Amrein, Hanno Hock, Gabriela Hobbs, Donna Neuberg, Timothy A. Graubert, Amir T. Fathi	1
3	Inhibition of ATR with AZD6738 (Ceralasertib) for the Treatment of Progressive or Relapsed Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: Safety and Preliminary Activity from a Phase Ib/II Study 2021 ·Blood ·Andrew M. Brunner, Yiwen Liu, Lourdes Mendez, Jacqueline S. Garcia, Philip C. Amrein, Donna Neuberg, Emma Dean, Simon A. Smith, Richard M. Stone, Amir T. Fathi, Matthew J. Walter, Timothy A. Graubert, Meagan A. Jacoby	6
4	A synthetic small molecule stalls pre-mRNA splicing by promoting an early-stage U2AF2-RNA complex 2021 ·Cell chemical biology ·Rakesh Chatrikhi, (unknown), Mary J. Pulvino, Georgios Alachouzos, (unknown), Zackary Falls, (unknown), William W. Brennessel, Jermaine L. Jenkins, Matthew J. Walter, Timothy A. Graubert, Ram Samudrala, Melissa S. Jurica, Alison J. Frontier, Clara L. Kielkopf	23
5	Spliceosome Mutations Induce R Loop-Associated Sensitivity to ATR Inhibition in Myelodysplastic Syndromes 2018 ·Cancer Research ·Hai Dang Nguyen, Wan Yee Leong, Weiling Li, Pavankumar N.G. Reddy, (unknown), Matthew J. Walter, Lee Zou, Timothy A. Graubert	115
6	Subclonal Evolution Characterizes MDS Disease Progression Following Allogeneic Stem Cell Transplant 2017 ·Blood ·Meagan A. Jacoby, Eric J. Duncavage, Gue Su Chang, Christopher A. Miller, Jin Shao, (unknown), Joshua D. Robinson, Robert S. Fulton, Catrina C. Fronick, Michelle D. O’Laughlin, Daniel C. Link, John F. DiPersio, Peter Westervelt, Timothy J. Ley, Timothy A. Graubert, Matthew J. Walter	1
7	Spliceosomal Mutations Induce R Loop-Associated ATR Signaling 2017 ·Blood ·Wan Yee Leong, Hai Dang Nguyen, Weiling Li, Matthew J. Walter, Lee Zou, Timothy A. Graubert	1
8	Case 37-2016 2016 ·New England Journal of Medicine ·Amir T. Fathi, Timothy A. Graubert, Naveen M. Kulkarni, Frank C. Kuo, Robert P. Hasserjian	1
9	Prognostic understanding, quality of life and mood in patients undergoing hematopoietic stem cell transplantation 2015 ·Bone Marrow Transplantation ·Areej El‐Jawahri, Luke Traeger, (unknown), Justin Eusebio, Harry VanDusen, Tanya E. Keenan, Jennifer Shin, Emily R. Gallagher, Joseph A. Greer, William F. Pirl, Vicki A. Jackson, Karen K. Ballen, Thomas R. Spitzer, Timothy A. Graubert, SL McAfee, B Dey, (unknown), Jennifer S. Temel	64
10	SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution 2014 ·PLoS Computational Biology ·Christopher A. Miller, Brian S. White, Nathan D. Dees, Malachi Griffith, John S. Welch, Obi L. Griffith, Ravi Vij, Michael H. Tomasson, Timothy A. Graubert, Matthew J. Walter, Matthew J. Ellis, William Schierding, John F. DiPersio, Timothy J. Ley, Elaine R. Mardis, Richard K. Wilson, Li Ding	281
11	POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature 2010 ·Leukemia ·(unknown), Jacqueline E. Payton, Patrick Cahan, Timothy J. Ley, Matthew J. Walter, Timothy A. Graubert	15
12	Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study 2009 ·Breast Cancer Research and Treatment ·Mike G. Martin, John S. Welch, Jingqin Luo, Matthew J. Ellis, Timothy A. Graubert, Matthew J. Walter	36
13	Therapy-Related Myelodysplastic Syndrome: Models and Genetics 2009 ·Biology of Blood and Marrow Transplantation ·Timothy A. Graubert	9
14	A Randomized Double-Blind Trial of Hydroxychloroquine for the Prevention of Chronic Graft-versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation 2007 ·Biology of Blood and Marrow Transplantation ·(unknown), Kathryn Trinkaus, Douglas R. Adkins, Ravi Vij, Steven M. Devine, Michael H. Tomasson, Lawrence T. Goodnough, (unknown), Timothy A. Graubert, Shalini Shenoy, John F. DiPersio, H. Jean Khoury	19
15	A High-Resolution Map of Segmental DNA Copy Number Variation in the Mouse Genome 2006 ·PLoS Genetics ·Timothy A. Graubert, Patrick Cahan, (unknown), Rebecca R. Selzer, Todd Richmond, Peggy S. Eis, William D. Shannon, Xia Li, Howard L. McLeod, James M. Cheverud, Timothy J. Ley	182
16	Sca-1 negatively regulates proliferation and differentiation of muscle cells 2005 ·Developmental Biology ·Patrick O. Mitchell, (unknown), Roddy S. O’Connor, Timothy A. Graubert, Elaine Dzierzak, Grace K. Pavlath	85
17	Dominant Negative Effects of the AML1/ETO Fusion Oncoprotein 2004 ·Cell Cycle ·Timothy S. Fenske, Gina Pengue, Timothy A. Graubert	3
18	A mouse-based strategy for cyclophosphamide pharmacogenomic discovery 2003 ·Journal of Applied Physiology ·James Watters, (unknown), Daniel C. Link, Timothy A. Graubert, Howard L. McLeod	27
19	Sca-1pos Cells in the Mouse Mammary Gland Represent an Enriched Progenitor Cell Population 2002 ·Developmental Biology ·Bryan E. Welm, (unknown), (unknown), Timothy A. Graubert, Jeffrey M. Rosen, Margaret A. Goodell	412
20	How do cytotoxic lymphocytes kill their targets? 1998 ·Current Opinion in Immunology ·Sujan Shresta, Christine T. N. Pham, Dori A. Thomas, Timothy A. Graubert, Timothy J. Ley	316

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact